Answer
Saxagliptin hydrochloride (Onglyza) is not recommended for children and adolescents because efficacy in children aged 10 to under 18 years has not been established, and Onglyza has not been studied in children under 10 years.
Sources for this answer
- Onglyza 5mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.2 Posology and method of administration · Version 26Document updated
Sources checked